KHPG(SZ:002773) Xin Lang Cai Jing·2025-10-29 03:03Core Insights - Kanghong Pharmaceutical (002773.SZ) reported its Q3 2025 results, revealing that 29 institutional investors hold a total of 372 million shares, accounting for 40.43% of the company's total equity [1] - The top ten institutional investors collectively hold 39.56% of the shares, with a decrease of 1.38 percentage points compared to the previous quarter [1] Institutional Holdings - The top ten institutional investors include Chengdu Kanghong Technology Industry Group Co., Ltd., Hong Kong Central Clearing Limited, Agricultural Bank of China - Dacheng RuiXiang Mixed Securities Investment Fund, and others [1] - The number of institutional investors holding shares has remained stable, with a slight decrease in the proportion held by the top ten [1] Public Fund Activity - In the current period, 13 public funds increased their holdings, with notable funds including Oriental Red Medical Upgrade Stock A and Baoying Medical Health Hong Kong-Shenzhen Stock A, representing an increase of 0.54% [2] - Conversely, 8 public funds reduced their holdings, including Dacheng Competitive Advantage Mixed A and Dacheng Strategy Return Mixed A, with a decrease of 0.59% [2] - Six new public funds disclosed their holdings this period, while 247 public funds did not disclose their holdings compared to the previous quarter [2] Foreign Investment - One foreign fund, Hong Kong Central Clearing Limited, increased its holdings slightly in the current period [2]